• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aclaris Therapeutics, Inc. - Common Stock (NQ:ACRS)

    3.600 -0.270 (-6.98%)
    Streaming Delayed Price Updated: 3:40 PM EST, Jan 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,266,554
    Open 3.900
    Bid (Size) 3.600 (900)
    Ask (Size) 3.610 (9,000)
    Prev. Close 3.870
    Today's Range 3.540 - 3.920
    52wk Range 1.050 - 4.890
    Shares Outstanding 107,850,124
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill
    Tuesday's session: top gainers and losers ↗
    Via Chartmill

    Performance

    YTD
    +25.0%
    +25.0%
    1 Month
    +19.6%
    +19.6%
    3 Month
    +50.6%
    +50.6%
    6 Month
    +132.3%
    +132.3%
    1 Year
    +46.9%
    +46.9%

    More News

    Read More
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Stock Market Today: US Future Edge Higher Ahead Of FOMC Decision—Meta, Microsoft Earnings In Focus ↗
    Via Benzinga
    News headline image
    Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
    Via Benzinga
    News headline image
    Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy ↗
    Via Benzinga
    News headline image
    Santa Rally, January Effect, And Top Stock Picks ↗
    Via Talk Markets
    Topics Stocks / Equities
    News headline image
    This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday ↗
    Via Benzinga
    News headline image
    Level Up Your Trading: Inside The 4-Pillar Strategy Behind Triple-Digit Returns ↗
    Via Talk Markets
    Topics Stocks / Equities
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments ↗
    Via Benzinga
    News headline image
    War, Gold, And Opportunity: Uncovering Today’s Market Moves ↗
    Via Talk Markets
    News headline image
    This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying ↗
    Via Benzinga
    News headline image
    3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
    Via MarketBeat
    News headline image
    Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying ↗
    Via Benzinga
    News headline image
    $1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗
    Via InvestorPlace

    Frequently Asked Questions

    Is Aclaris Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Aclaris Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Aclaris Therapeutics, Inc. - Common Stock trade on?
    Aclaris Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Aclaris Therapeutics, Inc. - Common Stock?
    The ticker symbol for Aclaris Therapeutics, Inc. - Common Stock is ACRS on the Nasdaq Stock Market
    What is the current price of Aclaris Therapeutics, Inc. - Common Stock?
    The current price of Aclaris Therapeutics, Inc. - Common Stock is 3.600
    When was Aclaris Therapeutics, Inc. - Common Stock last traded?
    The last trade of Aclaris Therapeutics, Inc. - Common Stock was at 01/28/26 03:40 PM ET
    What is the market capitalization of Aclaris Therapeutics, Inc. - Common Stock?
    The market capitalization of Aclaris Therapeutics, Inc. - Common Stock is 388.26M
    How many shares of Aclaris Therapeutics, Inc. - Common Stock are outstanding?
    Aclaris Therapeutics, Inc. - Common Stock has 388M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.